Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
Status:
Completed
Trial end date:
2015-01-31
Target enrollment:
Participant gender:
Summary
The primary objective of the study was to assess the efficacy of Dupilumab, compared to
placebo, in adult patients with moderate-to-severe atopic dermatitis (AD).